Ad is loading...
AIECX
Price
$19.15
Change
-$0.23 (-1.19%)
Updated
Nov 15 closing price
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

AIECX vs RERAX

Header iconAIECX vs RERAX Comparison
Open Charts AIECX vs RERAXBanner chart's image
Invesco EQV International Equity C
Price$19.15
Change-$0.23 (-1.19%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
AIECX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AIECX vs. RERAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIECX is a Sell and RERAX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. AIECX (2.52B). RERAX pays higher dividends than AIECX: RERAX (0.91) vs AIECX (0.14). AIECX was incepted earlier than RERAX: AIECX (27 years) vs RERAX (22 years). RERAX is a more actively managed with annual turnover of: 34.00 vs. AIECX (32.00). RERAX has a lower initial minimum investment than AIECX: RERAX (250) vs AIECX (1000). RERAX annual gain was more profitable for investors over the last year : 7.63 vs. AIECX (5.67). RERAX return over 5 years is better than : 3.85 vs. AIECX (-37.85).
AIECXRERAXAIECX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years22 years-
Gain YTD-0.4683.052-15%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.52B129B2%
Annual Yield % from dividends0.140.9116%
Returns for 1 year5.677.6374%
Returns for 3 years-36.78-19.45189%
Returns for 5 years-37.853.85-982%
Returns for 10 years-36.8415.89-232%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics